GW Pharmaceuticals Revenue Hits $137M, Tests Another Cannabis Plant-Based Drug
Biopharmaceutical company GW Pharmaceuticals plc (NASDAQ: GWPH) revealed Tuesday that its revenue for the third quarter hit $137.1 million, up by 51% year-over-year. For the first nine months of this fiscal year, total revenue amounted to $378.6 million versus $202.3 million for the same period of 2019. For the quarter, net loss was ... Read More